Retrieve available abstracts of 53 articles: HTML format
Single Articles
September 2025
ZHUANG Z, Zhang L, Wang Y USP2 alleviates MPP(+)-induced neuronal injury by stabilizing FOXC1 in SK-N-SH
cells.
Brain Res. 2025;1862:149689. PubMedAbstract available
August 2025
XU L, Deng J, Xiong W, Li L, et al Macrophages in the dCLN are required for alpha-synuclein proteostasis in A53T PD
model mice.
Brain Res. 2025;1860:149692. PubMedAbstract available
July 2025
CHEN H, Ding H, Huang D, Wu S, et al GBE1 alleviates MPTP-induced PD symptoms in mice by enhancing glycolysis and
oxidative phosphorylation.
Brain Res. 2025;1859:149663. PubMedAbstract available
SI Y, Yan S, Li X, Ding W, et al P2X7R activation promotes ferroptosis in dopaminergic neurons via NF-kappaB signaling
pathway in vitro and in vivo models of MPP(+)/MPTP-induced Parkinson's disease.
Brain Res. 2025 Jul 8:149824. doi: 10.1016/j.brainres.2025.149824. PubMedAbstract available
June 2025
XIE G, Yang Y, Zhang X, Chen Y, et al Tris (1,3-dichloro-2-propyl) phosphate (TDCPP) aggravates Parkinson's disease
neurotoxicity through ferroptosis-related oxidative stress and neuroinflammation.
Brain Res. 2025 Jun 25:149805. doi: 10.1016/j.brainres.2025.149805. PubMedAbstract available
May 2025
FOROOZANMEHR B, Hemmati MA, Yaribeygi H, Karav S, et al Parkinson's disease and brain insulin signaling: Mechanisms and potential role of
GLP-1 mimetics.
Brain Res. 2025;1862:149738. PubMedAbstract available
KATRIB C, Naidji C, Devos D, Timmerman K, et al Texture features of T2w magnetic resonance imaging mirror tissue changes in
Parkinson's disease models.
Brain Res. 2025 May 19:149717. doi: 10.1016/j.brainres.2025.149717. PubMedAbstract available
KAUR J, Sharma V, Khan H, Singh S, et al Intersecting molecular pathways in Synucleinopathies and Amyloidogenesis:
Exploring shared mechanisms and therapeutic potential.
Brain Res. 2025;1855:149568. PubMedAbstract available
HYDERI Z, Farhana M S, Singh TP, Ravi AV, et al Therapeutic Targeting of Autosomal Parkinson's Disease by Modulation of
Leucine-Rich Repeat Kinase 2 (LRRK2) Protein.
Brain Res. 2025;1860:149674. PubMedAbstract available
WANG HY, Liang Z, Yan Z, Liu Y, et al Neural mechanisms linking sleep disturbances to motor and cognitive impairments
in Parkinson's disease: Evidence from resting-state and task-based fNIRS.
Brain Res. 2025;1860:149681. PubMedAbstract available
April 2025
USMAN S, Mondal AC Menopause triggers microglia-associated neuroinflammation in Parkinson's disease.
Brain Res. 2025 Apr 16:149649. doi: 10.1016/j.brainres.2025.149649. PubMedAbstract available
COTRIN JC, Dos Santos Junior GC, Cadaxo AS, Pereira JS, et al Plasma and urinary metabolomic signatures differentiate genetic and idiopathic
Parkinson's disease.
Brain Res. 2025 Apr 7:149625. doi: 10.1016/j.brainres.2025.149625. PubMedAbstract available
March 2025
LIU Y, Cheng Y, Chen T, Wang J, et al Basal ganglia connectivity and network asymmetry in Parkinson's disease: A
resting-state fMRI study.
Brain Res. 2025 Mar 18:149576. doi: 10.1016/j.brainres.2025.149576. PubMedAbstract available
MANGANOTTI P, Liccari M, Maria Isabella Lombardo T, Della Toffola J, et al Effect of a single session of transcranial pulse stimulation (TPS) on resting
tremor in patients with Parkinson's disease.
Brain Res. 2025;1850:149405. PubMedAbstract available
February 2025
KUMAR D, Kumar R, Janrao S, Sharma V, et al Treadmill exercise mitigates rotenone-induced neuroinflammation and alpha-synuclein
level in a mouse model of Parkinson's disease.
Brain Res. 2025;1854:149540. PubMedAbstract available
SAMSON JS, Rajagopal K, Parvathi VD Outlook of SNCA (alpha-synuclein) transgenic fly models in delineating the sequel of
mitochondrial dysfunction in Parkinson's disease.
Brain Res. 2025;1852:149505. PubMedAbstract available
KOOB AO, Shaked GM, Bender A, Bisquertt A, et al Corrigendum to "Neurogranin binds alpha-synuclein in the human superior temporal
cortex and interaction is decreased in Parkinson's disease" [Brain Res. 1591
(2014) 102-110].
Brain Res. 2025 Feb 12:149504. doi: 10.1016/j.brainres.2025.149504. PubMed
DUTTA A, Roy R, Pandey M, Chhetry S, et al Arsenic-induced mice model of Parkinson's disease: Revealing the neurotoxicity of
arsenic through mitochondrial complexes inhibition and dopaminergic
neurodegeneration in the substantia nigra region of brain.
Brain Res. 2025;1851:149493. PubMedAbstract available
January 2025
USMAN JS, Wong TW, Ng SSM Effects of transcranial direct current stimulation combined with concurrent
dual-task walking on mobility, gait, and cognitive outcomes: A systematic review.
Brain Res. 2025;1846:149255. PubMedAbstract available
December 2024
SHARMA R, Thirugnanasambandam N Theta-Gamma Decoupling - A neurophysiological marker of impaired reward
processing in Parkinson's disease.
Brain Res. 2024 Dec 19:149406. doi: 10.1016/j.brainres.2024.149406. PubMedAbstract available
WEN B, Li X, Xu J, He Y, et al The mechanism of SiJunZi decoction in the treatment of Parkinson's disease.
Brain Res. 2024;1850:149397. PubMedAbstract available
August 2024
BHARDWAJ K, Jha A, Roy A, Kumar H, et al The crucial role of VPS35 and SHH in Parkinson's disease: Understanding the
mechanisms behind the neurodegenerative disorder.
Brain Res. 2024;1845:149204. PubMedAbstract available
LI Y, Wang Q, Zhang X, Zheng R, et al Characterization of D1R and D2R neuronal subpopulations in the globus pallidus
interna: Implications for Parkinson's disease pathogenesis.
Brain Res. 2024 Aug 19:149174. doi: 10.1016/j.brainres.2024.149174. PubMedAbstract available
LI J, Xu Y, Liu X, Yang F, et al Cortical morphological alterations in cognitively normal Parkinson's disease with
severe hyposmia.
Brain Res. 2024;1844:149150. PubMedAbstract available
SHAH S, Pushpa Tryphena K, Singh G, Kulkarni A, et al Neuroprotective role of Carvacrol via Nrf2/HO-1/NLRP3 axis in Rotenone-induced PD
mice model.
Brain Res. 2024;1836:148954. PubMedAbstract available
July 2024
CHATTERJEE A, Mohapatra J, Sharma M, Jha A, et al A novel selective NLRP3 inhibitor shows disease-modifying potential in animal
models of Parkinson's disease.
Brain Res. 2024 Jul 27:149129. doi: 10.1016/j.brainres.2024.149129. PubMedAbstract available
STATZ M, Weber H, Schleuter F, Kober M, et al Subthalamic nucleus deep brain stimulation induces functional deficits in
norepinephrinergic neurotransmission in a Parkinson's disease model.
Brain Res. 2024 Jul 23:149128. doi: 10.1016/j.brainres.2024.149128. PubMedAbstract available
June 2024
JIN M, Ye K, Hu D, Chen J, et al Identification of diagnose related therapeutic targets of Danggui buxue decoction
in Parkinson's disease.
Brain Res. 2024 Jun 29:149097. doi: 10.1016/j.brainres.2024.149097. PubMedAbstract available
MA LY, Jia B, Geng H, Liang J, et al Poly(rC)-binding protein 1 alleviates neurotoxicity in 6-OHDA-induced SH-SY5Y
cells and modulates glial cells in neuroinflammation.
Brain Res. 2024;1832:148863. PubMedAbstract available
May 2024
LI L, Chen Z, Hao C Neuroprotective effects of polyphyllin VI against rotenone-induced toxicity in
SH-SY5Y cells.
Brain Res. 2024;1830:148824. PubMedAbstract available
April 2024
HOFFMEISTER JD, Broadfoot CK, Schaen-Heacock NE, Lechner SA, et al Vocal and tongue exercise in early to mid-stage Parkinson disease using the
Pink1-/- rat.
Brain Res. 2024 Apr 27:148958. doi: 10.1016/j.brainres.2024.148958. PubMedAbstract available
CANSIZ D, Unal I, Gani Surmen M, Surmen S, et al Gentisic acid exerts neuroprotective effects in neurotoxin-induced Parkinson's
disease model in zebrafish: Cross-talk between pathways related with
neurodegeneration in the gut-brain axis.
Brain Res. 2024 Apr 19:148952. doi: 10.1016/j.brainres.2024.148952. PubMedAbstract available
March 2024
ROSTAMI Z, Salari M, Mahdavi S, Etemadifar M, et al Abnormal multisensory temporal discrimination in Parkinson's disease.
Brain Res. 2024 Mar 30:148901. doi: 10.1016/j.brainres.2024.148901. PubMedAbstract available
MANSOUR HM, Mohamed AF, Khattab MM, El-Khatib AS, et al Unveiling the therapeutic prospects of EGFR inhibition in rotenone-mediated
parkinsonism in rats: Modulation of dopamine D3 receptor.
Brain Res. 2024;1834:148893. PubMedAbstract available
GENG C, Tan L, Chenchen Neuropsychiatric symptoms profile and markers of Alzheimer disease-type pathology
in patients with Lewy body dementias.
Brain Res. 2024 Mar 20:148881. doi: 10.1016/j.brainres.2024.148881. PubMedAbstract available
December 2023
FLORES AJ, Bartlett MJ, Seaton BT, Samtani G, et al Antagonism of kappa opioid receptors accelerates the development of
L-DOPA-induced dyskinesia in a preclinical model of moderate dopamine depletion.
Brain Res. 2023;1821:148613. PubMedAbstract available
November 2023
SMIT RD, Ghosh B, Campion TJ 3rd, Stingel R, et al STAT3 protects dopaminergic neurons against degeneration in animal model of
Parkinson's disease.
Brain Res. 2023;1824:148691. PubMedAbstract available
LIU X, Liu X, Liu Y, Yang B, et al Utility of serum neurofilament light chain and glial fibrillary acidic protein as
diagnostic biomarkers of freezing of gait in Parkinson's disease.
Brain Res. 2023;1822:148660. PubMedAbstract available
ZHANG L, Guo Y, Liu J, Li L, et al Transcranial direct current stimulation of the prefrontal cortex improves
depression-like behaviors in rats with Parkinson's disease.
Brain Res. 2023 Nov 1:148649. doi: 10.1016/j.brainres.2023.148649. PubMedAbstract available
October 2023
ISMAEL S, Colvin RA, Lee D Activation of cyclic AMP signaling pathway in dopaminergic neurons rescues
locomotion defects in a Drosophila larval model of Parkinson's disease.
Brain Res. 2023 Oct 20:148641. doi: 10.1016/j.brainres.2023.148641. PubMedAbstract available
September 2023
YIN N, Wang H, Wang Z, Feng K, et al A study of brain networks associated with Freezing of gait in Parkinson's disease
using transfer entropy analysis.
Brain Res. 2023 Sep 30:148610. doi: 10.1016/j.brainres.2023.148610. PubMedAbstract available
CABRAL LM, Oliveira LM, Miranda NC, Kawamoto EM, et al TNFR1-mediated neuroinflammation is necessary for respiratory deficits observed
in 6-hydroxydopamine mouse model of Parkinsons Disease.
Brain Res. 2023 Sep 25:148586. doi: 10.1016/j.brainres.2023.148586. PubMedAbstract available
SONG J, Zhao Y, Shan X, Luo Y, et al Active ingredients of Chinese medicine with immunomodulatory properties: NF-kappaB
pathway and Parkinson's disease.
Brain Res. 2023 Sep 23:148603. doi: 10.1016/j.brainres.2023.148603. PubMedAbstract available
August 2023
UNAL I, Cansiz D, Beler M, Sezer Z, et al Sodium-dependent Glucose Co-Transporter-2 Inhibitor Empagliflozin Exerts
Neuroprotective Effects in Rotenone-Induced Parkinson's Disease Model in
Zebrafish; Mechanism Involving Ketogenesis and Autophagy.
Brain Res. 2023 Aug 15:148536. doi: 10.1016/j.brainres.2023.148536. PubMedAbstract available
June 2023
KHOT M, Sood A, Pushpa Tryphena K, Pinjala P, et al Dimethyl fumarate ameliorates Parkinsonian pathology by modulating autophagy and
apoptosis via Nrf2-TIGAR-LAMP2/Cathepsin D axis.
Brain Res. 2023 Jun 12:148462. doi: 10.1016/j.brainres.2023.148462. PubMedAbstract available
RAI P, Ratnaparkhi A, Kumar Roy J Rab11 rescues muscle degeneration and synaptic morphology in the park(13/+)
Parkinson model of Drosophila melanogaster.
Brain Res. 2023 Jun 9:148442. doi: 10.1016/j.brainres.2023.148442. PubMedAbstract available
OLIVEIRA LM, Severs L, Moreira TS, Ramirez JM, et al Ampakine CX614 increases respiratory rate in a mouse model of Parkinson's
disease.
Brain Res. 2023;1815:148448. PubMedAbstract available
ZHOU W, He J, Zhang C, Pan Y, et al Fiber-specific white matter alterations in Parkinson's disease patients with
freezing of gait.
Brain Res. 2023 Jun 2:148440. doi: 10.1016/j.brainres.2023.148440. PubMedAbstract available
May 2023
HENRIQUE BINDA K, Landau AM, Chacur M, Brooks DJ, et al Treadmill exercise modulates nigral and hippocampal cannabinoid receptor type 1
in the 6-OHDA model of Parkinson's disease.
Brain Res. 2023 May 31:148436. doi: 10.1016/j.brainres.2023.148436. PubMedAbstract available
ROUZITALAB A, Boulay CB, Sachs AJ Volitional Control of Beta Activities in Parkinson's Disease Patients.
Brain Res. 2023 May 6:148394. doi: 10.1016/j.brainres.2023.148394. PubMedAbstract available
April 2023
CONTI MAZZA MM, Centner A, Werner DF, Bishop C, et al Striatal serotonin transporter gain-of-function in L-DOPA-treated,
hemi-parkinsonian rats.
Brain Res. 2023 Apr 29:148381. doi: 10.1016/j.brainres.2023.148381. PubMedAbstract available
March 2023
BOSCH TJ, Espinoza AI, Singh A Cerebellar oscillatory dysfunction during lower-limb movement in Parkinson's
disease with freezing of gait.
Brain Res. 2023;1808:148334. PubMedAbstract available
NING B, Wang Z, Wu Q, Deng Q, et al Acupuncture inhibits autophagy and repairs synapses by activating the mTOR
pathway in Parkinson's disease depression model rats.
Brain Res. 2023 Mar 11:148320. doi: 10.1016/j.brainres.2023.148320. PubMedAbstract available